In 1941, the Tata Memorial Hospital in Bombay, India was opened. It was developed by the Sir Dorabji Tata Trust. The Indian Cancer Research Centre followed with its opening in 1952.
It was later renamed the Cancer Research Institute. In 1966 these two divisions combined to form the Tata Memorial Centre. The hospital sees approximately 43,000 patients a year, 60% of which are cancer patients.
Of the patients that they see for cancer treatment, over 70% are attended to at almost no charge.
The hospital’s main focus is the research and treatment of cancer related illnesses with Radiotherapy, Chemotherapy and surgery as the most common treatments. The Tata Memorial Hospital practices Evidence Based Medicine which is diagnosis and care based on clinical research. In 1983 the hospital was the first to perform a bone marrow transplant.
In 1997 the hospital organized the Hospital Scientific Review Committee. The purpose of this committee was to set a high benchmark in clinical research, to create hospital wide guidelines for clinical trials, to integrate the relations between the hospital and Cancer Research Institute, and to uphold the hospital’s high standing as a cancer treatment facility.
Tata Memorial Hospital has designed a specific center designated for the performance and review of clinical trials known as the D.A.E. Clinical Trial Center. The hospital has sixteen medical departments including Biochemistry, Cytology, Hemato-Pathology, and Radiodiagnosis. The Biochemistry department is comprised of three sub-departments: the main Biochemistry Lab, tumor marker services and emergency care. The department of Biochemistry is certified by the NABL.
| 
